However, recent studies demonstrate that HER2+ tumor cells can acquire an osteoblastic phenotype, actively producing hydroxyapatite crystals through activation of epithelial-mesenchymal transition (EMT) and the expression of genes such as BMP-2, RUNX2, and osteopontin [20]. The gene discussed is BMP2; the disease is neoplasm.